10-Q

Company

Arbutus Biopharma Corp

Filed

August 3, 2023

Period of Report

June 30, 2023

Accession Number

0001447028-23-000082

A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →